- Release Date: 30/09/21 09:21
- Summary: Zantrene highly effective in Melanoma preclinical study
- Price Sensitive: Yes
- Download Document 827.42KB
Ann: Zantrene highly effective in Melanoma preclinical study
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.62 |
Change
-0.040(2.41%) |
Mkt cap ! $280.3M | |||
| Open | High | Low | Value | Volume |
| $1.68 | $1.68 | $1.62 | $36.98K | 22.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 10000 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.62 | 17462 | 3 |
View Market Depth
| Last trade - 13.57pm 05/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |